ACTIENT PHARMACEUTICALS LLC – Trademark Portfolio
Entity Type: 16
ACTIENT PHARMACEUTICALS LLC holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 9 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 8 trademarks are registered. Notable registered marks include EDEX, ACTIENT, LEVATOL, SEMPREX, and STRIANT. The owner is based in Malvern, PA.
1400 Atwater Drive
Malvern, PA 19355
Showing of trademarks Trademarks
Trademark Classifications
ACTIENT PHARMACEUTICALS LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does ACTIENT PHARMACEUTICALS LLC have?
ACTIENT PHARMACEUTICALS LLC has 11 U.S. trademarks filed with the USPTO. Of these, 8 registered, 3 cancelled.
What trademark classes does ACTIENT PHARMACEUTICALS LLC file in?
ACTIENT PHARMACEUTICALS LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are ACTIENT PHARMACEUTICALS LLC's most well-known trademarks?
ACTIENT PHARMACEUTICALS LLC's registered trademark portfolio includes well-known marks such as EDEX, ACTIENT, LEVATOL, SEMPREX, and STRIANT. These are among 8 currently registered trademarks in the portfolio.
What is ACTIENT PHARMACEUTICALS LLC's trademark registration success rate?
ACTIENT PHARMACEUTICALS LLC has a 73% trademark registration rate, with 8 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.